130 related articles for article (PubMed ID: 37454962)
1. Trends in the use of indocyanine green for sentinel lymph node mapping in vulvar cancer.
Matsuo K; Chen L; Robison K; Klar M; Roman LD; Wright JD
Am J Obstet Gynecol; 2023 Oct; 229(4):466-468. PubMed ID: 37454962
[No Abstract] [Full Text] [Related]
2. Robot-assisted Sentinel Lymph Node Mapping and Inguinal Lymph Node Dissection Using Near-infrared Fluorescence in Vulvar Cancer.
Mohammad A; Hunter MI
J Minim Invasive Gynecol; 2019; 26(5):968-972. PubMed ID: 30959199
[TBL] [Abstract][Full Text] [Related]
3. Evolution and outcomes of sentinel lymph node mapping in vulvar cancer.
Broach V; Abu-Rustum NR; Sonoda Y; Brown CL; Jewell E; Gardner G; Chi DS; Zivanovic O; Leitao MM
Int J Gynecol Cancer; 2020 Mar; 30(3):383-386. PubMed ID: 32075896
[TBL] [Abstract][Full Text] [Related]
4. Double identification of sentinel lymph node with indocyanine green and 99m-technetium in vulvar cancer and V-Y flap for vulvar reconstruction.
Vázquez-Vicente D; Campillo F; Boria F; Castellanos T; Guillen EF; Chiva L
Int J Gynecol Cancer; 2021 Feb; 31(2):300-301. PubMed ID: 33229409
[No Abstract] [Full Text] [Related]
5. Accuracy of ICG compared with technetium-99 m for sentinel lymph node biopsy in vulvar cancer.
Guijarro-Campillo AR; Padilla-Iserte P; Couso B; Erasun D; Utrilla-Layna J; Arencibia O; Boldo-Roda A; Gilabert-Estellés J; Veiga N; Lago V; Cárdenas-Rebollo JM; Domingo S
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():11-19. PubMed ID: 38183845
[TBL] [Abstract][Full Text] [Related]
6. Sentinel Lymph Node Evaluation in Early-Stage Vulvar Cancer.
Penn CA; Schneiter MK; Watson CH
Curr Treat Options Oncol; 2024 Jan; 25(1):20-26. PubMed ID: 38170388
[TBL] [Abstract][Full Text] [Related]
7. Sentinel Lymphadenectomy in Vulvar Cancer Using Near-Infrared Fluorescence From Indocyanine Green Compared With Technetium 99m Nanocolloid.
Soergel P; Hertel H; Nacke AK; Klapdor R; Derlin T; Hillemanns P
Int J Gynecol Cancer; 2017 May; 27(4):805-812. PubMed ID: 28399034
[TBL] [Abstract][Full Text] [Related]
8. Detection rates of sentinel lymph node in vulvar cancer using the new protocol with indocyanine-green fluorescence: Time to abandon both blue dye as well as 99mTc-labeled colloid lymphoscintigraphy protocols?
Iavazzo C; Vrachnis N; Gkegkes ID
Eur J Surg Oncol; 2023 Apr; 49(4):875. PubMed ID: 36379861
[No Abstract] [Full Text] [Related]
9. Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?
Darin MC; Gómez-Hidalgo NR; Westin SN; Soliman PT; Escobar PF; Frumovitz M; Ramirez PT
J Minim Invasive Gynecol; 2016 Feb; 23(2):186-93. PubMed ID: 26518716
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of indocyanine green fluorescence guided sentinel lymph node biopsy in vulvar cancer: A systematic review.
Koual M; Benoit L; Nguyen-Xuan HT; Bentivegna E; Azaïs H; Bats AS
Gynecol Oncol; 2021 May; 161(2):436-441. PubMed ID: 33551201
[TBL] [Abstract][Full Text] [Related]
11. Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer.
Hutteman M; van der Vorst JR; Gaarenstroom KN; Peters AA; Mieog JS; Schaafsma BE; Löwik CW; Frangioni JV; van de Velde CJ; Vahrmeijer AL
Am J Obstet Gynecol; 2012 Jan; 206(1):89.e1-5. PubMed ID: 21963099
[TBL] [Abstract][Full Text] [Related]
12. A comparison of ICG-NIR with blue dye and technetium for the detection of sentinel lymph nodes in vulvar cancer.
Rundle S; Korompelis P; Ralte A; Bewick D; Ratnavelu N
Eur J Surg Oncol; 2023 Feb; 49(2):481-485. PubMed ID: 36207232
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy versus inguinofemoral lymphadenectomy in vulvar cancer patients with micrometastases in the sentinel node].
Marnitz S; Bereuter AS
Strahlenther Onkol; 2022 Jun; 198(6):595-597. PubMed ID: 35415784
[No Abstract] [Full Text] [Related]
14. Is solo indocyanine green-guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?
Perez-Ardavin J; Mir MC
BJU Int; 2024 Jan; 133(1):44-45. PubMed ID: 37731159
[No Abstract] [Full Text] [Related]
15. Sentinel lymph node biopsy for vulvar melanoma: trends in tumor stage-specific utilization.
Bainvoll L; Brunette LL; Muderspach LI; Khetan VU; Roman LD; Klar M; Matsuo K
Am J Obstet Gynecol; 2022 Mar; 226(3):438-440. PubMed ID: 34757005
[No Abstract] [Full Text] [Related]
16. Sentinel lymph node biopsy using indocyanine green in penile cancer.
Brunckhorst O; Ahmed K; Alnajjar HM; Muneer A
Nat Rev Urol; 2020 Oct; 17(10):541-542. PubMed ID: 32572209
[No Abstract] [Full Text] [Related]
17. Feasibility of sentinel lymph node mapping of the ovary: a systematic review.
Dell'Orto F; Laven P; Delle Marchette M; Lambrechts S; Kruitwagen R; Buda A
Int J Gynecol Cancer; 2019 Sep; 29(7):1209-1215. PubMed ID: 31474589
[TBL] [Abstract][Full Text] [Related]
18. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
19. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
[TBL] [Abstract][Full Text] [Related]
20. [Lymph node mapping and sentinel node detection in gynecological oncology].
Pityński K; Basta A
Ginekol Pol; 2002 Nov; 73(11):1159-64. PubMed ID: 12722417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
